BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 26847090)

  • 1. Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders.
    Frederick MC; Cameron MH
    Curr Neurol Neurosci Rep; 2016 Mar; 16(3):26. PubMed ID: 26847090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumefactive demyelinating lesions.
    Dagher AP; Smirniotopoulos J
    Neuroradiology; 1996 Aug; 38(6):560-5. PubMed ID: 8880719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical inflammatory demyelinating syndromes of the CNS.
    Hardy TA; Reddel SW; Barnett MH; Palace J; Lucchinetti CF; Weinshenker BG
    Lancet Neurol; 2016 Aug; 15(9):967-981. PubMed ID: 27478954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical inflammatory demyelinating lesions and atypical multiple sclerosis.
    Ayrignac X; Carra-Dallière C; Labauge P
    Rev Neurol (Paris); 2018 Jun; 174(6):408-418. PubMed ID: 29673573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review.
    Karussis D
    J Autoimmun; 2014; 48-49():134-42. PubMed ID: 24524923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants of multiple sclerosis.
    Simon JH; Kleinschmidt-DeMasters BK
    Neuroimaging Clin N Am; 2008 Nov; 18(4):703-16, xi. PubMed ID: 19068410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients.
    Balloy G; Pelletier J; Suchet L; Lebrun C; Cohen M; Vermersch P; Zephir H; Duhin E; Gout O; Deschamps R; Le Page E; Edan G; Labauge P; Carra-Dallieres C; Rumbach L; Berger E; Lejeune P; Devos P; N'Kendjuo JB; Coustans M; Auffray-Calvier E; Daumas-Duport B; Michel L; Lefrere F; Laplaud DA; Brosset C; Derkinderen P; de Seze J; Wiertlewski S;
    J Neurol; 2018 Oct; 265(10):2251-2259. PubMed ID: 30054790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balo's concentric sclerosis: An atypical demyelinating disease in pediatrics.
    Arenas Vargas LE; Bedoya Morales AM; Rincón Carreño C; Espitia Segura OM; Penagos N
    Mult Scler Relat Disord; 2020 Sep; 44():102198. PubMed ID: 32531753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelinoclastic diffuse sclerosis (Schilder's disease) is immunologically distinct from multiple sclerosis: results from retrospective analysis of 92 lumbar punctures.
    Jarius S; Haas J; Paul F; Wildemann B
    J Neuroinflammation; 2019 Feb; 16(1):51. PubMed ID: 30819213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the overlap between multiple sclerosis, tumefactive demyelination and Baló's concentric sclerosis.
    Hardy TA; Tobin WO; Lucchinetti CF
    Mult Scler; 2016 Jul; 22(8):986-92. PubMed ID: 27037180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic criteria of borderline forms of multiple sclerosis].
    Dupel-Pottier C
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):935-43. PubMed ID: 11787358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balo's concentric lesions with concurrent features of Schilder's disease in relapsing multiple sclerosis: neuropathological findings.
    Kurdi M; Ramsay D
    Autops Case Rep; 2016; 6(4):21-26. PubMed ID: 28210570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired inflammatory white matter disease.
    Gallucci M; Caulo M; Cerone G; Masciocchi C
    Childs Nerv Syst; 2001 Apr; 17(4-5):202-10. PubMed ID: 11398938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marburg type and Balò's concentric sclerosis: rare and acute variants of multiple sclerosis.
    Capello E; Mancardi GL
    Neurol Sci; 2004 Nov; 25 Suppl 4():S361-3. PubMed ID: 15727234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons from the neuropathology of atypical forms of multiple sclerosis.
    Stadelmann C; Brück W
    Neurol Sci; 2004 Nov; 25 Suppl 4():S319-22. PubMed ID: 15727225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotyping variants of tumefactive demyelinating lesions according to clinical and radiological features-A case series.
    Boyle T; Fernando SL; Drummond J; Fontes A; Parratt J
    Front Neurol; 2023; 14():1092373. PubMed ID: 36816572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathology and definition of multiple sclerosis].
    Dutta R; Trapp BD
    Rev Prat; 2006 Jun; 56(12):1293-8. PubMed ID: 16948216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Borderlines types of multiple sclerosis].
    De Seze J
    Rev Neurol (Paris); 2006 Jan; 162(1):137-43. PubMed ID: 16446632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudotumoral Demyelinating Lesions: A Presentation of Acute Disseminated Encephalomyelitis.
    Belfkih R; Khayat OG; H'daidane H; El Amrani FZ
    Case Rep Neurol; 2021; 13(2):289-296. PubMed ID: 34177535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumefactive demyelinating lesions: A comprehensive review.
    Algahtani H; Shirah B; Alassiri A
    Mult Scler Relat Disord; 2017 May; 14():72-79. PubMed ID: 28619436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.